3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
30
Oropharyngeal Neoplasms
21
Nasopharyngeal Carcinoma
15
Head and Neck Neoplasms
13
Prostatic Neoplasms
11
Laryngeal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Carcinoma, Squamous Cell
8
Carcinoma
8
Breast Neoplasms
8
Rectal Neoplasms
7
Mouth Neoplasms
7
Hypopharyngeal Neoplasms
7
Glioma
6
Glioblastoma
6
Uterine Cervical Neoplasms
5
Papillomavirus Infections
5
Esophageal Neoplasms
5
Urinary Bladder Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Nasopharyngeal Neoplasms
4
Astrocytoma
4
Mesothelioma, Malignant
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Tumor Virus Infections
2
Tongue Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
Radiotherapy, Intensity-Modulated
×
1 year
×
Clear all
No trials found.